Unlearn experts outline current reality of AI-powered digital twins and the steps needed to actualize the technology’s potential in clinical practice The manuscript explores the transformative ...
Using novel digital twins of clinical trial participants, Unlearn is accelerating clinical research to help bring new treatments to patients sooner SAN FRANCISCO--(BUSINESS WIRE)--Unlearn®, an AI ...
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates ...
Unlearn seems to have retained a lesson or two about fundraising: The digital twin developer announced this week that it has raised another $50 million, echoing its last funding round two years ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback